Etoposide Ebewe 20 mg/ml, concentrate for solution for infusion Malta - inglés - Medicines Authority

etoposide ebewe 20 mg/ml, concentrate for solution for infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Etoposide Concentrate For Solution For Infusion Kenia - inglés - Pharmacy and Poisons Board

etoposide concentrate for solution for infusion

etoposide - concentrate for solution for infusion - 20 mg/ml - etoposide

VEPESID etoposide 100mg capsule blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

vepesid etoposide 100mg capsule blister pack

link medical products pty ltd t/a link pharmaceuticals - etoposide, quantity: 100 mg - capsule - excipient ingredients: iron oxide red; gelatin; purified water; glycerol; sodium propyl hydroxybenzoate; citric acid; sodium ethyl hydroxybenzoate; titanium dioxide; macrogol 400 - 1 - small cell carcinoma of the lung 2 - acutre monocytic and myelomoncytic leukaemia 3 - hodgkins disease 4 - non-hodgkins lymphoma indications as at 5 october 2000: in the treatment of: 1. small cell carcinoma of the lung. 2. acute monocytic and myelomonocytic leukaemia. 3. hodgkin's disease. 4. non-hodgkin's lymphoma.

Etoposide Australia - inglés - Department of Health (Therapeutic Goods Administration)

etoposide

sandoz pty ltd - etoposide -

Etoposide (Pfizer) Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

etoposide (pfizer)

pharmacia limited company trading as pharmacia - etoposide 20mg - solution for injection - 20 mg/ml - active: etoposide 20mg excipient: citric acid ethanol macrogol 300 polysorbate 80

Etoposide (Pacific) Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

etoposide (pacific)

viatris limited - etoposide 20 mg/ml - solution for infusion - 100 mg/5ml - active: etoposide 20 mg/ml excipient: benzyl alcohol citric acid ethanol macrogol 300 nitrogen polysorbate 80

ETOPOSIDE INJECTION 100 mg5 ml Singapur - inglés - HSA (Health Sciences Authority)

etoposide injection 100 mg5 ml

pfizer private limited - etoposide - injection - 100 mg/5 ml - etoposide 100 mg/5 ml

Etoposide Injection 100 mg/5 mL (1) Australia - inglés - Department of Health (Therapeutic Goods Administration)

etoposide injection 100 mg/5 ml (1)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - - small cell carcinoma of the lung. - acute monocytic and myelomonocytic leukaemia. - hodgkin's disease - non-hodgkin's lymphoma.

Etoposide 100 mg/5 mL Injection (Bulk) Australia - inglés - Department of Health (Therapeutic Goods Administration)

etoposide 100 mg/5 ml injection (bulk)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - for the treatment of small cell lung cancer and testicular tumours, either as a single agent or in combination with other anticancer agents.

Etoposide injection 100 mg in 5 mL (3) Australia - inglés - Department of Health (Therapeutic Goods Administration)

etoposide injection 100 mg in 5 ml (3)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - etoposide is primarily used for the treatment of testicular tumours, in combination with bleomycin and cisplatin, and in combination with cisplatin for small-cell carcinoma of the lung. it is also active against non-hodgkin?s lymphomas, acute nonlymphocytic leukemia, carcinoma of the breast and kaposi?s sarcoma associated with acquired immunodeficiency syndrome (aids).